Microsurgical Technology (MST) has announced a strategic partnership with Japanese manufacturer Mani...

The U.S. Food and Drug Administration (FDA) has accepted Regeneron’s supplemental Biologics License ...

Biocon Biologics has announced a settlement and license agreement with Regeneron, enabling the futur...

Atsena Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted Regen...

Eyestem Research has announced encouraging results from its Phase 1 clinical trial (NCT06394232) eva...

Nextech and Ocuco have entered a strategic partnership aimed at delivering a fully integrated, end-t...

Pykus Therapeutics has successfully completed patient enrollment in its pilot clinical study, PYK-21...

Vantage Biosciences has officially dosed the first patient in its Phase 2 clinical trial evaluating ...

Oculis Holding has announced the completion of patient enrollment in both DIAMOND-1 and DIAMOND-2, t...

Harrow has announced the expansion of its Vevye Access for All (VAFA) program, now extending eligibi...